Evidence map›Paper›PMID 35454129›Full record

ArticleBiomolecules2022

Regulatory Crosstalk between Physiological Low O

Véronique Labat, Eva Nguyen van Thanh Dit Bayard, Alice Refeyton, Mathilde Huart, Maryse Avalon, Christelle Debeissat, Laura Rodriguez, Philippe Brunet de la Grange, Zoran Ivanovic, Marija Vlaski-Lafarge

Abstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Véronique LabatR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Eva Nguyen van Thanh Dit BayardR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Alice RefeytonR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Mathilde HuartR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.ORCID 0000-0002-7735-9279
Maryse AvalonR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Christelle DebeissatR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Laura RodriguezR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.
Philippe Brunet de la GrangeR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.ORCID 0000-0001-5002-6012
Zoran IvanovicR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.ORCID 0000-0001-6158-0270
Marija Vlaski-LafargeR&D Department, Etablissement Français du Sang Nouvelle-Aquitaine, 33075 Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiological low oxygen (O2) concentration (<5%) favors erythroid development ex vivo. It is known that low O2 concentration, via the stabilization of hypoxia-induced transcription factors (HIFs), intervenes with Notch signaling in the control of cell fate. In addition, Notch activation is implicated in the regulation of erythroid differentiation. We test here if the favorable effects of a physiological O2 concentration (3%) on the amplification of erythroid progenitors implies a cooperation between HIFs and the Notch pathway. To this end, we utilized a model of early erythropoiesis ex vivo generated from cord blood CD34+ cells transduced with shHIF1α and shHIF2α at 3% O2 and 20% O2 in the presence or absence of the Notch pathway inhibitor. We observed that Notch signalization was activated by Notch2R−Jagged1 ligand interaction among progenitors. The inhibition of the Notch pathway provoked a modest reduction in erythroid cell expansion and promoted erythroid differentiation. ShHIF1α and particularly shHIF2α strongly impaired erythroid progenitors’ amplification and differentiation. Additionally, HIF/NOTCH signaling intersects at the level of multipotent progenitor erythroid commitment and amplification of BFU-E. In that, both HIFs contribute to the expression of Notch2R and Notch target gene HES1. Our study shows that HIF, particularly HIF2, has a determining role in the early erythroid development program, which includes Notch signaling.

Indexed as

Erythroid Precursor CellsErythropoiesisCell DifferentiationCells, CulturedFetal BloodOxygenOxygenBFU-ECD34+ cellsCFU-EdifferentiationerythropoiesisHIFlow O2 concentrationNotchprogenitors

Identifiers

PMID35454129
PMCPMC9028139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.